Royal Gold
RGLD Nasdaq Gold Financials FY2016βFY2025
Royal Gold's revenue rose 43.2% to $1.0 billion in fiscal 2025. Its operating margin was 61.9%, up from 59.8% a year earlier. It paid out $119 million in dividends and buybacks. The diluted share count rose 5.8%.
About these figures. Royal Gold changed its fiscal year end from June 30 to December 31 in 2021, so fiscal 2021 ends in June 2021 and the six months to December 2021 aren't shown. Royal Gold buys streams and royalties on other companies' mines rather than running mines itself; those purchases aren't capital spending on property and equipment, so capital spending, free cash flow and property and equipment are blank.
What Royal Gold does
No business description yet.
- Legal name
- Royal Gold, Inc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000085535-26-000008
0000085535
Revenue and margins
Royal Gold had $1.0B of revenue in fiscal 2025, up 43.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Royal Gold returned $119M to shareholders in fiscal 2025. The diluted share count rose 5.8%.
Value Royal Gold yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$662M and divides by 69.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 25.2x Β· peers 33.3x Β· sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Royal Gold can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $226M | $119M | $104M | $196M | $234M |
| Debt incl. finance leases | β | $572M | $246M | $0.0M | $895M |
| Net debt / EBITDA | β | 1.0x | 0.3x | β0.3x | 0.8x |
| Debt / equity | β | 0.2x | 0.1x | 0.0x | 0.1x |
| Interest coverage | 96.2x | 39.3x | 10.8x | 65.2x | 32.8x |
| Current ratio | 5.7x | 2.9x | 2.3x | 3.2x | 3.1x |
| Quick ratio | 5.7x | 2.9x | 2.3x | 3.2x | 3.1x |
| Total assets | $2.7B | $3.5B | $3.4B | $3.4B | $9.5B |
| Total liabilities | $148M | $781M | $460M | $261M | $2.3B |
| Shareholders' equity | $2.5B | $2.7B | $2.9B | $3.1B | $7.2B |
| Net debt (β = net cash) | β | $453M | $142M | β$196M | $662M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.8M
7 insiders
Of sales under plans
49%
$2.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | William Holmes HeissenbuttelPresident & CEO, Director | Sold plan | 7,275 | $263.38 | $1.9M | Form 4 |
| Aug 28, 2026 | Randy ShefmanSVP & General Counsel | Sold | 500 | $262.80 | $0.1M | Form 4 |
| Jun 16, 2026 | Randy ShefmanSVP & General Counsel | Sold | 500 | $215.85 | $0.1M | Form 4 |
| May 11, 2026 | Randy ShefmanSVP & General Counsel | Sold | 1,000 | $243.74 | $0.2M | Form 4 |
| Mar 12, 2026 | Mark IstoDirector | Sold | 2,000 | $274.83 | $0.5M | Form 4 |
| Mar 4, 2026 | Paul LibnerSVP & CFO | Sold plan | 3,200 | $283.47 | $0.9M | Form 4 |
| Mar 2, 2026 | Daniel BreezeSVP Corp Dev of RGLD Gold AG | Sold | 1,400 | $300.87 | $0.4M | Form 4 |
| Feb 20, 2026 | William M. HayesDirector | Sold | 4,173 | $277.07 | $1.2M | Form 4 |
| Dec 17, 2025 | Ronald J VanceDirector | Sold | 300 | $218.53 | $0.1M | Form 4 |
| Dec 11, 2025 | Ronald J VanceDirector | Sold | 500 | $218.29 | $0.1M | Form 4 |
| Dec 4, 2025 | Daniel BreezeSVP Corp Dev of RGLD Gold AG | Sold | 970 | $202.23 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 8 / 9 | 6 / 9 |
| Accruals ratio | β5.1% | β5.9% | β3.7% |
| Altman Z'' | 8.05 | 14.68 | 4.29 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Royal Gold RGLD | $19.4B | 43.2% | 61.9% | β | 9.7% | 25.2x | 6 | |
| Coeur Mining CDE | $13.9B | 96.4% | 34.2% | 32.2% | β | β | β | Compare β |
| Newmont NEM | $114.4B | 21.3% | β | 32.2% | 20.6% | 12.7x | 8 | Compare β |
| Balchem BCPC | $5.7B | 8.8% | 20.2% | 16.7% | β | 33.3x | β | Compare β |
| Hawkins HWKN | $2.8B | 11.2% | 11.2% | 7.9% | 13.1% | 34.3x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $289M | $441M | $459M | $423M | $499M | $616M | $603M | $606M | $719M | $1.0B |
| Gross profit | $289M | $192M | $209M | $179M | $236M | $333M | $323M | $343M | $471M | $714M |
| Operating income | $4.8M | $146M | β$74.5M | $141M | $199M | $338M | $284M | $303M | $430M | $638M |
| Interest expense | $17.7M | $19.0M | $16.0M | $1.7M | $4.9M | $3.5M | $7.2M | $28.1M | $6.6M | $19.5M |
| Pretax income | β$21.8M | $119M | β$105M | $107M | $193M | $340M | $273M | $282M | $426M | $574M |
| Income tax | $60.7M | $26.4M | $14.8M | $17.5M | β$3.7M | $36.9M | $32.9M | $42.0M | $93.6M | $102M |
| Net income | β$77.1M | $102M | β$113M | $93.8M | $199M | $303M | $239M | $239M | $332M | $466M |
| Diluted EPS | β$1.18 | $1.55 | β$1.73 | $1.43 | $3.03 | $4.60 | $3.63 | $3.63 | $5.04 | $6.69 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $169M | $267M | $329M | $253M | $341M | $407M | $417M | $416M | $530M | $705M |
| Depreciation and amortization | $141M | $160M | $164M | $163M | $175M | $184M | $179M | $165M | $144M | $177M |
| Stock-based compensation | $10.0M | $10.0M | $8.3M | $6.6M | $9.1M | $5.7M | $8.4M | $9.7M | $11.9M | $11.8M |
| Acquisitions | $1.3B | $204M | $11.8M | $1.1M | $156M | $168M | $0.0M | $0.0M | $0.0M | $411M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $58.7M | $61.4M | $64.1M | $67.5M | $71.5M | $76.1M | $91.9M | $98.6M | $105M | $119M |
| Dividends and buybacks | $58.7M | $61.4M | $64.1M | $67.5M | $71.5M | $76.1M | $91.9M | $98.6M | $105M | $119M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $117M | $85.8M | $88.8M | $120M | $319M | $226M | $119M | $104M | $196M | $234M |
| Total debt | $601M | $586M | $351M | $215M | $300M | β | $572M | $246M | $0.0M | $895M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $168M | $144M | $126M | $155M | $362M | $297M | $186M | $167M | $275M | $377M |
| Current liabilities | $25.9M | $34.3M | $51.4M | $33.6M | $43.6M | $52.1M | $63.6M | $72.4M | $85.2M | $121M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $3.1B | $3.1B | $2.7B | $2.5B | $2.8B | $2.7B | $3.5B | $3.4B | $3.4B | $9.5B |
| Total liabilities | $784M | $774M | $541M | $374M | $464M | $148M | $781M | $460M | $261M | $2.3B |
| Shareholders' equity | $2.2B | $2.3B | $2.1B | $2.1B | $2.3B | $2.5B | $2.7B | $2.9B | $3.1B | $7.2B |
| Margins | ||||||||||
| Gross margin | 100.0% | 43.6% | 45.6% | 42.2% | 47.3% | 54.1% | 53.6% | 56.7% | 65.5% | 69.3% |
| Operating margin | 1.7% | 33.1% | β16.2% | 33.3% | 39.9% | 54.8% | 47.0% | 50.1% | 59.8% | 61.9% |
| EBITDA margin | 50.5% | 69.3% | 19.4% | 71.8% | 75.1% | 84.6% | 76.7% | 77.3% | 79.8% | 79.1% |
| Net margin | β26.7% | 23.0% | β24.7% | 22.2% | 40.0% | 49.1% | 39.6% | 39.5% | 46.2% | 45.3% |
| Returns | ||||||||||
| Return on capital | 0.2% | 4.1% | β2.3% | 5.0% | 8.8% | β | β | 8.3% | 11.2% | 9.7% |
| Return on capital employed | 0.2% | 4.8% | β2.6% | 5.5% | 7.6% | 12.7% | 9.4% | 9.0% | 13.0% | 10.0% |
| Return on equity | β3.4% | 4.5% | β5.2% | 4.4% | 9.0% | 12.7% | 9.1% | 8.5% | 11.1% | 9.1% |
| Return on assets | β2.6% | 3.3% | β3.9% | 3.6% | 7.5% | 11.2% | 7.7% | 6.9% | 9.8% | 7.2% |
| Growth | ||||||||||
| Revenue growth | 18.1% | 52.6% | 4.1% | β7.8% | 17.9% | 23.5% | β2.1% | 0.4% | 18.8% | 43.2% |
| Net income growth | β248.5% | β | β211.4% | β | 112.5% | 51.8% | β21.0% | 0.2% | 38.7% | 40.4% |
| EPS growth | β247.5% | β | β211.6% | β | 111.9% | 51.8% | β21.1% | 0.0% | 38.8% | 32.7% |
| Share count change | β0.1% | 0.3% | 0.0% | 0.3% | 0.2% | β0.0% | 0.1% | 0.1% | 0.1% | 5.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.3x | 1.6x | 2.9x | 0.3x | β0.1x | β | 1.0x | 0.3x | β0.3x | 0.8x |
| Debt / equity | 0.3x | 0.3x | 0.2x | 0.1x | 0.1x | β | 0.2x | 0.1x | 0.0x | 0.1x |
| Interest coverage | 0.3x | 7.7x | β4.6x | 82.8x | 40.6x | 96.2x | 39.3x | 10.8x | 65.2x | 32.8x |
| Current ratio | 6.5x | 4.2x | 2.5x | 4.6x | 8.3x | 5.7x | 2.9x | 2.3x | 3.2x | 3.1x |
| Quick ratio | 6.5x | 4.2x | 2.5x | 4.6x | 8.3x | 5.7x | 2.9x | 2.3x | 3.2x | 3.1x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 3.5% | 2.3% | 1.8% | 1.6% | 1.8% | 0.9% | 1.4% | 1.6% | 1.7% | 1.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 6.0 | 5.0 | 7.0 | 7.0 | β | β | 5.0 | 8.0 | 6.0 |
| Altman Z'' | 3.4 | 3.8 | 4.0 | 6.7 | 6.5 | 19.6 | 5.0 | 8.1 | 14.7 | 4.3 |
| Accruals ratio | β8.2% | β5.4% | β15.3% | β6.1% | β5.3% | β3.9% | β5.8% | β5.1% | β5.9% | β3.7% |
Source: SEC EDGAR XBRL filings (CIK 0000085535). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.